| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Automated Cell Shakers Market Size 2024 |
USD 698 Million |
| Automated Cell Shakers Market, CAGR |
6.9% |
| Automated Cell Shakers Market Size 2032 |
USD 1190.3 Million |
Market Overview:
Automated Cell Shakers Market size was valued at USD 698 million in 2024 and is anticipated to reach USD 1190.3 million by 2032, at a CAGR of 6.9% during the forecast period (2024-2032).
Key market drivers include the accelerating demand for biologics and cell-based therapies, which has significantly increased the need for standardized, contamination-free cell culture conditions. Additionally, the growth of bioprocessing applications, particularly in drug development and vaccine production, is boosting the adoption of automated cell shaking systems. The growing shift toward lab automation in both academic and industrial settings is reinforcing this trend. Furthermore, advancements in precision engineering and the integration of digital interfaces in laboratory instruments are enabling enhanced user control, real-time data acquisition, and programmable operations, further supporting market expansion. Increasing collaborations between biotech firms and research institutions are also playing a crucial role in the adoption of automated systems. In addition, the need to minimize human error and enhance reproducibility in research is further encouraging automation. The rise of continuous bioprocessing techniques is also increasing the demand for equipment capable of sustained and uniform culture agitation. Moreover, stringent regulatory requirements for consistent quality and documentation in biomanufacturing processes are driving the shift to automated and validated equipment.
Regionally, North America holds the largest share of the global market, driven by a well-established biotechnology sector, strong R&D funding, and widespread adoption of lab automation tools. The Asia-Pacific region is expected to witness the fastest growth, fueled by increasing investments in pharmaceutical research, expanding biopharma manufacturing capacities, and supportive government initiatives across countries like China, India, and South Korea. Meanwhile, Europe continues to represent a mature market, benefitting from a strong academic research ecosystem and growing emphasis on biosimilars and biologic drug development. The Middle East and Latin America are also emerging as potential growth regions due to rising healthcare investments and infrastructure improvements. The global market is witnessing heightened competition, with key players focusing on innovation, product customization, and regional expansion to strengthen their positions. Additionally, government-supported life sciences initiatives and biotech park developments in emerging economies are attracting international manufacturers. Increased emphasis on laboratory modernization and training is also accelerating the regional adoption of automated cell shakers.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download Sample
Market Insights:
- The Automated Cell Shakers Market was valued at USD 698 million in 2024 and is projected to reach USD 1,190.3 million by 2032, expanding at a CAGR of 6.9% during the forecast period.
- Rising demand for biologics and cell-based therapies is driving market growth, as automated cell shakers ensure contamination-free, high-quality cultures critical for biopharmaceutical production.
- The expansion of vaccine manufacturing and bioprocessing applications has accelerated the adoption of automated shakers that support consistent mixing and yield optimization.
- Laboratories are increasingly embracing automation to meet regulatory standards, minimize manual error, and enhance experimental reproducibility across research and clinical environments.
- Smart technologies such as IoT integration, real-time monitoring, and programmable interfaces are enhancing user control and operational efficiency in modern laboratory setups.
- High capital costs and skill shortages in operating advanced systems remain key challenges, especially for smaller labs with limited budgets and technical expertise.
- North America leads the market with a 36% share, followed by Asia-Pacific at 28% and Europe at 22%, each driven by distinct factors such as biotech investment, industrial expansion, and regulatory compliance.
Market Drivers:
Rising Demand for Biologics and Cell-Based Therapies Accelerates Market Growth
The Automated Cell Shakers Market is gaining traction due to the expanding need for biologics and cell-based therapies across pharmaceutical and biotechnology sectors. These therapies require high-quality, contamination-free cell cultures, which automated shakers help maintain. The precision and consistency of automated systems support standardized culturing conditions, critical for the development of therapeutic proteins and regenerative medicine. Pharmaceutical companies are investing in scalable equipment to meet rising clinical trial and commercial production requirements. Manual handling methods fall short in terms of repeatability and sterility, prompting a shift toward automated solutions. The market benefits from this transition as biologics continue to dominate the global drug pipeline.
Expansion of Bioprocessing and Vaccine Manufacturing Fuels Equipment Adoption
Automated Cell Shakers Market growth is supported by the rise in global bioprocessing activities, particularly in vaccine development and production. These systems provide uniform mixing and stable environmental conditions that improve yield and quality during cultivation. The COVID-19 pandemic reinforced the need for agile and efficient production platforms, encouraging companies to upgrade their laboratory infrastructure. With global health agencies promoting preparedness, demand for biomanufacturing equipment remains high. It meets the need for scalable processes in both upstream and downstream operations. Governments and private stakeholders continue funding research initiatives, driving further adoption of automated shakers.
- For instance, the Thermo Scientific Cytomat 2 C-LiN automated incubator provides a temperature range from 4°C to 70°C and achieves a mean access time of 12 seconds for microplates, supporting rapid and reliable cell culture operations.
Laboratory Automation Initiatives Promote Consistency and Efficiency
The market is experiencing sustained growth due to widespread automation initiatives across academic, diagnostic, and industrial laboratories. Automated Cell Shakers Market supports this trend by offering solutions that reduce manual errors and improve reproducibility. Laboratories increasingly rely on automation to meet stringent regulatory standards and tight project timelines. It plays a crucial role in enhancing operational efficiency and maintaining batch-to-batch consistency in experimental setups. Workflow automation also reduces labor costs and improves equipment utilization. With growing emphasis on productivity, the market sees rising investment in integrated automated systems.
- For instance, Mayo Medical Laboratories implemented a sort automation system capable of processing 6,000 test tubes per hour, which doubled throughput and reduced mis-sorts from 20–30 specimens per day to zero.
Technological Advancements Enhance Equipment Performance and User Experience
Recent technological advancements have significantly improved the capabilities of cell shakers, contributing to the market’s evolution. It now features programmable settings, touchscreen interfaces, and real-time monitoring for precise control. These improvements enable researchers to adjust variables such as speed, temperature, and timing with high accuracy. The integration of IoT and data analytics enhances traceability and operational feedback. Automated Cell Shakers Market benefits from demand for equipment that supports compliance and documentation. Equipment standardization across multi-site facilities further accelerates adoption among contract research and manufacturing organizations.
Market Trends:
Integration of Smart Technologies and IoT Drives Intelligent Laboratory Operations
The Automated Cell Shakers Market is witnessing a strong trend toward smart technology integration, driven by the need for real-time monitoring, precision, and remote control. Modern cell shakers now feature IoT connectivity, cloud-based data storage, and programmable control interfaces that enable researchers to track and optimize operations with minimal manual intervention. It allows laboratories to ensure repeatability and compliance while reducing operational errors. These smart systems support data logging for regulatory audits and provide alerts for system failures or deviations. The demand for equipment that integrates seamlessly with broader lab automation platforms is growing across pharmaceutical and academic research settings. Manufacturers are responding by developing interoperable solutions that enhance scalability and improve digital workflow management.
- For instance, the Thermo Scientific IntelliStack Incubator Shaker features a 10-inch color touchscreen interface, real-time monitoring, and the ability to program up to 12 customized protocol steps, supporting precise control and data export via USB or Ethernet.
Shift Toward Modular and Scalable Platforms to Support Flexible Bioprocessing
Flexibility and scalability have become core trends in laboratory and bioprocessing environments, pushing demand for modular equipment. The Automated Cell Shakers Market reflects this shift with increasing preference for systems that can adapt to varied volumes, vessel formats, and process scales. It enables users to transition efficiently from research-scale experiments to pilot and production-scale operations. Modular designs offer easy integration with incubators, bioreactors, and robotic handling systems. This flexibility supports a wide range of applications, including cell line development, protein expression, and stem cell research. As biomanufacturing strategies evolve, the market sees rising interest in platforms that can be reconfigured without disrupting existing workflows.
- For instance, Ori Biotech’s IRO platform has been validated in over 500 runs with ten different partners across multiple cell types and protocols.
Market Challenges Analysis:
High Capital Investment and Maintenance Costs Limit Adoption in Small Laboratories
The Automated Cell Shakers Market faces a major challenge due to the high upfront costs associated with advanced equipment. Small and mid-sized laboratories often struggle to justify the capital expenditure required for automation, especially when operating under tight budgets. It becomes more difficult when ongoing maintenance, calibration, and potential repair costs are factored in. Many institutions continue to rely on manual or semi-automated systems to avoid financial strain. The lack of flexible pricing models or rental options restricts wider adoption. Cost remains a significant barrier in expanding access to these technologies in resource-limited environments.
Technical Complexity and Skill Gaps Hinder Operational Efficiency
Sophisticated automated systems require specialized training, which poses challenges for laboratories with limited technical expertise. The Automated Cell Shakers Market must address the learning curve associated with programming, customization, and troubleshooting of equipment. It becomes a barrier for teams that lack skilled personnel or experience with digital laboratory tools. Downtime due to operational errors or improper configuration affects productivity and data reliability. Without adequate support or user-friendly interfaces, institutions face delays in implementation. Bridging the skill gap is essential to fully realize the benefits of automation across various research and production settings.
Market Opportunities:
Growing Demand in Emerging Markets Creates New Revenue Streams
The Automated Cell Shakers Market has significant opportunities in emerging economies due to rising investments in biotechnology and life sciences infrastructure. Countries such as India, Brazil, and South Korea are expanding research capabilities and building local biomanufacturing hubs. It offers vendors the chance to introduce cost-effective and scalable solutions tailored to regional needs. Government-backed healthcare and pharmaceutical initiatives are driving procurement of advanced laboratory tools. Local partnerships and distribution networks can help companies gain competitive advantage in these fast-developing regions. Expanding presence in these markets will support long-term growth and diversification.
Rising Focus on Personalized Medicine and Cell Therapy Opens Niche Segments
The increasing focus on personalized treatments and cell-based therapies is creating new application areas for automated cell shakers. The Automated Cell Shakers Market is positioned to support labs working with stem cells, gene editing, and patient-specific biologics. It enables precise environmental control, which is essential for delicate and complex cultures. Research institutions and biopharma companies are seeking automation to improve reproducibility and reduce manual intervention. Demand for small-batch, high-purity production systems is also growing. Targeting these specialized applications offers opportunities for product differentiation and premium offerings.
Market Segmentation Analysis:
By Product
Platform shakers hold the largest share in this segment due to their versatility in handling multiple flasks and dishes simultaneously. Their simplicity, reliability, and compatibility with different vessel sizes make them widely used across research and industrial laboratories. Incubator shakers follow closely, offering integrated temperature control for sensitive cell lines and long-duration experiments. Orbital and reciprocating shakers cater to more specialized applications, where motion type and agitation pattern must match specific culture requirements. It enables researchers to fine-tune cultivation conditions for optimal results.
- For instance, the Thermo Scientific MaxQ 2000 Benchtop Open-Air Platform Shaker supports a maximum platform load of 35 lbs and offers a speed range of 15 to 500 rpm.
By Application
Cell culture dominates the Automated Cell Shakers Market, driven by its critical role in biopharmaceutical research, regenerative medicine, and vaccine development. Automated systems enhance reproducibility and sterility, which are essential in culturing mammalian cells. Microbial culture also accounts for a significant portion, particularly in enzyme production, fermentation, and synthetic biology research. It supports rapid microbial growth under controlled agitation, improving yield and product quality. Other applications such as protein expression and tissue engineering are expanding due to increased adoption of precision-based bioprocessing tools.
- For instance, the Eppendorf New Brunswick S41i CO₂ Incubator Shaker supports up to 10 × 1L Erlenmeyer flasks and maintains CO₂ control at ±0.1% for optimal cell culture conditions.
By End-Use
Pharmaceutical and biotechnology companies represent the largest end-use segment, relying on automated shakers for research, development, and production of biologics. It ensures consistent performance under regulated environments, supporting quality assurance and compliance. Academic and research institutions use automated shakers to meet experimental precision and reduce human error. Contract research organizations (CROs) are expanding usage to manage growing outsourced project volumes. Hospitals and diagnostic labs are emerging users, particularly in translational research and clinical cell processing applications.
Segmentations:
By Product
- Platform Shakers
- Incubator Shakers
- Orbital Shakers
- Reciprocating Shakers
By Application
- Cell Culture
- Microbial Culture
- Protein Expression
- Tissue Engineering
By End-Use
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Hospitals and Diagnostic Laboratories
By Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis:
North America Maintains Market Leadership with Strong Biotech and Academic Ecosystem
North America holds 36% of the global Automated Cell Shakers Market, making it the largest regional segment in 2024. The region’s dominance is supported by its robust biotechnology ecosystem, advanced laboratory infrastructure, and strong investment in life sciences R&D. It benefits from a high concentration of pharmaceutical companies and research institutions that rely on automation for large-scale and high-precision applications. Government funding initiatives and innovation-focused policies continue to promote the adoption of cutting-edge laboratory equipment. The presence of major industry players and contract research organizations further accelerates growth. North America maintains stable demand due to its leadership in biologics and cell-based therapy development.
Asia-Pacific Emerges as the Fastest-Growing Region Due to Industrial Expansion
Asia-Pacific accounts for 28% of the global Automated Cell Shakers Market and is projected to record the highest growth rate during the forecast period. The region’s expansion is driven by rising investments in biopharmaceutical manufacturing and research infrastructure in countries such as China, India, Japan, and South Korea. It benefits from growing domestic demand, government-backed healthcare programs, and increasing participation in global clinical trials. International companies are actively forming joint ventures and expanding production bases in the region. The availability of skilled professionals and cost-efficient operations strengthens Asia-Pacific’s competitive edge. Rising demand for vaccines, biosimilars, and regenerative medicine supports sustained adoption of automated systems.
Europe Maintains Steady Growth with Emphasis on Quality and Compliance
Europe holds 22% of the global Automated Cell Shakers Market, supported by stringent regulatory frameworks and high-quality research standards. It sees steady demand across public and private laboratories, especially in countries such as Germany, France, the U.K., and Switzerland. The focus on biosimilar development and standardized lab practices drives investment in automation technologies. It benefits from EU-funded research initiatives and strong academic–industry collaboration. Compliance with Good Manufacturing Practices (GMP) and data reproducibility requirements makes automation essential for many institutions. The region’s commitment to quality and scientific excellence continues to foster long-term market stability.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis:
- Corning Incorporated
- Thermo Fisher Scientific Inc.
- Eppendorf AG
- Grant Instruments
- Ohaus Corporation
- Boekel Scientific
- VELP Scientifica Srl
- Benchmark Scientific
- Kuhner Shaker
- Infors AG
Competitive Analysis:
The Automated Cell Shakers Market features a competitive landscape with several global and regional players focusing on product innovation, technology integration, and geographic expansion. Leading companies invest in automation, IoT features, and digital interfaces to improve user experience and operational efficiency. It remains highly innovation-driven, with firms aiming to meet evolving demands in biopharmaceutical research and manufacturing. Strategic collaborations with research institutes and biopharma companies are strengthening market presence. Players also focus on offering modular and scalable systems to support flexible lab setups. North America and Europe serve as strongholds for established brands, while Asia-Pacific offers new opportunities through local partnerships and expansion into emerging markets. Pricing strategies and after-sales service play a critical role in maintaining customer loyalty. Continuous product upgrades and regulatory compliance are central to sustaining competitiveness across diverse end-user segments.
Recent Developments:
- In February 2025, Thermo Fisher Scientific announced the acquisition of Solventum’s Purification & Filtration business for $4.1 billion to expand its bioprocessing capabilities.
- In June 2025, Thermo Fisher Scientific launched the Orbitrap Astral Zoom and Orbitrap Excedion Pro mass spectrometers, advancing high-resolution mass spectrometry.
- In June 2025, Ohaus Corporation launched the Frontier™ 5706P Multi Centrifuge, offering a compact design and powerful performance.
Market Concentration & Characteristics:
The Automated Cell Shakers Market is moderately concentrated, with a mix of established global manufacturers and emerging regional players competing on innovation, pricing, and service quality. It is characterized by high product standardization, growing demand for customization, and a strong focus on precision and reproducibility. Key players differentiate through advanced features such as programmable settings, real-time monitoring, and integration with laboratory automation platforms. The market favors companies that offer scalable and modular systems tailored to varied research and production needs. It demands compliance with stringent regulatory standards, particularly in pharmaceutical and biopharma applications. The need for technical support and training also shapes customer preferences, making service reliability a key competitive factor.
Report Coverage:
The research report offers an in-depth analysis based on Product, Application, End-Use and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- Market growth will accelerate as laboratories adopt end-to-end automation workflows, integrating cell shakers with robotic systems.
- It will increasingly feature IoT-enabled monitoring and analytics to support predictive maintenance and process optimization.
- Customizable shaker systems will gain popularity, allowing users to adapt setups for varied vessel types and experimental requirements.
- Demand will increase for systems that support continuous bioprocessing, including perfusion and fed-batch cultivation protocols.
- Platform expansion into cell and gene therapy applications will offer new opportunities in personalized medicine and regenerative research.
- Manufacturers will invest in enhanced user interfaces and cloud-based control to improve usability and remote operation.
- It will support traceability and compliance through integration with laboratory information management systems (LIMS) and electronic batch records.
- Manufacturers will explore modular add-ons such as temperature control units and gas exchange modules to enhance versatility.
- Strategic partnerships between equipment vendors and academic or biotech institutions will spur application-specific product development.
- It will see increased adoption in emerging markets, supported by local manufacturing, training programs, and favorable government policies.
